28,490 resources
By Version
By Authority
By Realm
Start Prev Rows 1600 - 1800 Next
Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Auth | Source(s) |
---|---|---|---|---|---|---|---|---|---|---|
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.898 | PIM_Loop_Diuretics | active | 2024-04 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.899 | PIM_Inhaled_Corticosteroids_(ICS) | active | 2025-03 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.9 | ACE inhibitors | active | 2024-12 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.90 | ASCVD I10 | active | 2023-09 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.900 | PIM_Leukotrienes | active | 2024-04 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.901 | OIA_Asthma_COPD_Meds_Inhalers | active | 2025-04 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.902 | OIA_Asthma_COPD_Meds_Nebulizers | active | 2024-04 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.903 | OIA_Asthma_COPD_Meds_Oral | active | 2024-04 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.904 | OIA_GLP1_Injectables | active | 2024-04 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.905 | OIA_Insulin_Injectables | active | 2024-04 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.906 | OIA_Oral_Hypoglycemics | active | 2024-12 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.907 | OIA_DM1_DM2_Meds | active | 2024-10 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.908 | Medium Dose ICS Formoterol | active | 2024-05 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.909 | High Dose ICS Formoterol | active | 2024-05 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.910 | CKD stage5OrESRD I10 | active | 2024-05 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.911 | CKD stage5OrESRD SCT | active | 2024-05 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.912 | CKD stage5OrESRD | active | 2024-05 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.914 | Anxiety_I10 | active | 2024-06 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.915 | Anxiety_SCT | active | 2024-06 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.916 | Anxiety | active | 2024-06 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.918 | Stress_SCT | active | 2024-06 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.919 | Stress_I10 | active | 2024-06 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.920 | Stress | active | 2024-06 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.921 | PBH_Anxiety_SCT | active | 2024-06 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.922 | PBH_Depression_SCT | active | 2024-06 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.923 | PBH_Stress_SCT | active | 2024-06 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.924 | PBH_Insomnia_SCT | active | 2024-06 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.925 | PIM_CMP_CPTs | active | 2024-06 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.926 | Canagliflozin meds | active | 2024-07 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.927 | Empagliflozin meds | active | 2024-07 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.928 | Dapagliflozin meds | active | 2024-07 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.929 | Ertugliflozin meds | active | 2024-07 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.930 | Dulaglutide meds | active | 2024-07 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.931 | Liraglutide meds | active | 2024-07 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.932 | Semaglutide SC meds | active | 2024-07 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.933 | T2DM meds benefitting ASCVD | active | 2024-07 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.934 | T2DM meds benefitting CKD stages 2, 3, and 4 with eGFR >= 20 mL/min | active | 2024-07 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.935 | T2DM meds benefitting CKD stage 5 | active | 2024-07 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.936 | T2DM meds benefitting HF with eGFR >= 20 mL/min | active | 2024-07 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.938 | Crohn disease SCT | active | 2024-10 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.939 | Crohn disease I10 | active | 2024-10 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.940 | Crohn disease | active | 2024-10 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.941 | Celiac disease SCT | active | 2024-10 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.942 | Celiac disease I10 | active | 2024-10 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.943 | Celiac disease | active | 2024-10 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.944 | OIA_Bisoprolol | active | 2024-10 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.945 | OIA_PVD_ICD10 | active | 2024-10 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.946 | Vibration Controlled Transient Elastography (VCTE) | active | 2024-12 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.947 | OIA_Antihypertensive_Medications | active | 2024-10 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.950 | OIA_CAD_ICD10 | active | 2024-10 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.951 | OIA_DM_ICD10 | active | 2024-10 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.952 | OIA_Creatinine_Levels_LOINC | active | 2024-10 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.953 | OIA_DM_SNOMEDCT | active | 2024-10 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.954 | OIA_CAD_SNOMEDCT | active | 2024-10 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.955 | OIA_PVD_SNOMEDCT | active | 2024-10 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.956 | OIA_DM_ICD10_SNOMEDCT | active | 2024-10 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.957 | OIA_CAD_ICD10_SNOMEDCT | active | 2024-10 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.958 | OIA_PVD_ICD10_SNOMEDCT | active | 2024-10 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.959 | ACEi for HFrEF | active | 2025-01 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.960 | ARB for HFrEF | active | 2024-12 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.961 | OIA_AntiHTN_Meds_Inclusion_List | active | 2024-11 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.962 | OIA_Thiazide_Diuretics | active | 2024-11 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.963 | OIA_RFs_ACS_ICD10 | active | 2024-12 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.964 | OIA_RFs_ACS_SNOMED | active | 2024-12 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.965 | OIA_RFs_ACS__ICD10_SNOMED | active | 2024-12 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.966 | OIA_Aortic_Calcifications_ICD10 | active | 2025-01 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.967 | OIA_Aortic_Calcifications_SNOMED | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.968 | OIA_Aortic_Calcifications_ICD10_SNOMED | active | 2025-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.969 | OIA_Microalbumin | active | 2025-01 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.97 | Sulfonylurea AllergyIntolerance SCT | active | 2023-09 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.970 | OIA_LDL_Cholesterol | active | 2025-01 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.971 | Pioglitazone | active | 2025-01 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.972 | MASLD I10 | active | 2025-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.973 | MASLD SCT | active | 2025-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.975 | OIA_Sulfonylureas | active | 2025-01 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.978 | OIA_RFs_ASCVD_ICD10 | active | 2025-01 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.979 | OIA_RFs_ASCVD_SNOMED | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.98 | BMI LOINC | active | 2024-03 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.980 | OIA_RFs_ASCVD_ICD10_SNOMED | active | 2025-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.981 | OIA_TIA_ICD10 | active | 2025-01 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.982 | OIA_TIA_SNOMED | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.983 | OIA_TIA_ICD10_SNOMED | active | 2025-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.984 | OIA_Angina_ICD10 | active | 2025-01 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.985 | OIA_Angina_SNOMED | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.987 | OIA_Angina_ICD10_SNOMED | active | 2025-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.988 | OIA_Ischemic_Hemorrhagic_Stroke_ICD10 | active | 2025-01 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.989 | OIA_Ischemic_Hemorrhagic_Stroke_SNOMED | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.990 | OIA_Ischemic_Hemorrhagic_Stroke_ICD10_SNOMED | active | 2025-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.991 | OIA_Myocardial_Infarction_ICD10 | active | 2025-01 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.992 | OIA_Myocardial_Infarction_SNOMED | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.993 | OIA_Myocardial_Infarction_ICD10_SNOMED | active | 2025-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.995 | OIA_PAD_ICD10 | active | 2025-01 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.996 | OIA_PAD_SNOMED | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.997 | OIA_PAD_ICD10_SNOMED | active | 2025-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.998 | OIA_Coronary_Arterial_Revascularization | active | 2025-01 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1080.5 | Contact or Office Visit | active | 2022-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1080.6 | Contact or Office Visit | active | 2025-02 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1080.7 | Contact or Office Visit | active | 2022-02 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.10 | Nutrition Diagnosis SNOMED CT | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.101 | Hospice Status | active | 2024-10 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.14 | Vitamin Mineral Supplement and Bioactive Substance Management SNOMED CT | active | 2020-08 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.17 | Pediatric Enteral Formulas SNOMED CT | active | 2021-04 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.18 | Modified Amino Acid Formulas SNOMED CT | active | 2024-04 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.19 | Nutrition Counseling Approach and Strategies SNOMED CT | active | 2020-09 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.20 | Enteral Nutrition Management SNOMED CT | active | 2020-09 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.21 | Nutrition Assessment | active | 2024-01 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.25 | Nutritional Status Severely Malnourished | active | 2016-12 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.30 | Malnutrition Risk Screening | active | 2015-11 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.31 | Malnutrition At Risk | active | 2015-11 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.32 | Malnutrition Risk Screening | active | 2016-12 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.34 | Malnutrition Screening Finding of Not At Risk Result | active | 2024-01 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.35 | Malnutrition Screening Not at Risk | active | 2015-11 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.38 | Malnutrition Screening Finding of At Risk Result | active | 2025-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.39 | Malnutrition Risk Screening | active | 2016-12 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.40 | Malnutrition Risk Screening | active | 2022-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.41 | Nutritional Status Severely Malnourished | active | 2025-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.42 | Nutrition Assessment Status Finding of Severely Malnourished | active | 2024-12 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.43 | Nutrition Assessment Status Finding of Severely Malnourished | active | 2024-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.44 | Nutrition Assessment Status Finding of Moderately Malnourished | active | 2024-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.45 | Nutritional Status Moderately Malnourished | active | 2015-11 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.46 | Nutritional Status Moderately Malnourished | active | 2025-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.47 | Nutrition Assessment Status Finding of Moderately Malnourished | active | 2024-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.48 | Nutrition Assessment Status Finding of Well Nourished or Not Malnourished or Mildly Malnourished | active | 2024-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.49 | Nutrition Focused Physical Findings Grouping | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.5 | Adult Enteral Formulas SNOMED CT | active | 2024-04 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.50 | Enteral Nutrition Composition SNOMED CT | active | 2024-04 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.51 | Enteral Nutrition Composition Grouping | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.52 | Parenteral Nutrition Management SNOMED CT | active | 2020-09 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.53 | Malnutrition Diagnosis | active | 2024-12 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.54 | Malnutrition Diagnosis | active | 2025-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.55 | Malnutrition Diagnosis | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.56 | Malnutrition Diagnosis | active | 2016-09 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.59 | Diet Item Grouping | active | 2018-04 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.60 | Edible Substances | active | 2021-04 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.61 | Feeding Device SNOMED CT | active | 2021-04 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.65 | Nutrition Recommendation Grouping | active | 2025-02 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.7 | Modular Nutrition Formulas SNOMED CT | active | 2021-04 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.71 | Coordination of Care by a Nutrition Professional SNOMED CT | active | 2024-04 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.73 | Nutrition Anthropometric Measurement SNOMED CT | active | 2024-05 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.74 | Nutrition Anthropometric Measure Panel LOINC | active | 2024-05 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.75 | Nutrition Anthropometric Measurements Grouping | active | 2018-04 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.76 | Manage Feeding Environment | active | 2021-04 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.77 | Special Food Items and Regime/Therapy for Special Food Items SNOMED CT | active | 2021-04 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.78 | Food and Nutrition Related History LOINC | active | 2024-04 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.79 | Nutrition Encounter Individual and Group CPT | active | 2025-02 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.80 | Nutrition Encounters HCPCS | active | 2025-02 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.81 | Nutrition Encounter Codes Grouping | active | 2018-04 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.84 | Food and Nutrition Related History SNOMED CT | active | 2024-04 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.87 | Feeding Device Grouping | active | 2018-05 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.88 | Nutrition Intervention Care Planning | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.89 | Malnutrition Screening Finding of At Risk Result | active | 2024-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.90 | Medical Nutrition Therapy Procedures | active | 2025-03 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.91 | Dietitian Referral | active | 2024-12 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.92 | Malnutrition Risk Screening | active | 2024-01 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.93 | Nutrition Care Plan | active | 2024-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.94 | Malnutrition Screening Finding of At Risk Result | active | 2024-01 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.95 | Nutrition Assessment Status Finding of Well Nourished or Not Malnourished or Mildly Malnourished | active | 2024-01 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.96 | Nutrition Assessment Status Finding of Well Nourished or Not Malnourished or Mildly Malnourished | active | 2024-01 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.97 | Nutrition Assessment Status Finding of Severely Malnourished | active | 2024-01 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.98 | Nutrition Assessment Status Finding of Moderately Malnourished | active | 2024-01 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.1 | Findings Related to Medication Management, Referral Source | active | 2023-12 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.100 | Recommendations Related to Medication Regimen | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.101 | Interventions Related to Medication Regimen, Initiate Medication | active | 2017-08 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.102 | Interventions Related to Medication Regimen, Change Medication | active | 2021-03 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.103 | Interventions Related to Medication Regimen, Change Medication Dose | active | 2024-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.104 | Interventions Related to Medication Regimen, Change Medication Dosage Form | active | 2017-08 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.105 | Interventions Related to Medication Regimen, Change Medication Course | active | 2017-08 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.106 | Interventions Related to Medication Regimen, Change Medication Dosing Interval | active | 2017-08 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.107 | Interventions Related to Medication Regimen, Discontinue Medication | active | 2017-08 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.109 | Interventions Related to Medication Regimen | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.11 | Interventions Related to Medication Management, Medication Reconciliation | active | 2017-08 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.110 | Interventions Related to Education, Medications | active | 2020-08 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.111 | Interventions Related to Education, Medical Equiptment and Devices | active | 2023-12 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.112 | Interventions Related to Medication Management, Notifications | active | 2017-08 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.113 | Interventions Related to Medication Management, Refill Synchronization | active | 2017-08 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.114 | Status of Patient Condition | active | 2017-08 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.115 | Interventions Related to Education, Diseases and Disorders | active | 2023-12 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.116 | Interventions Related to Education | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.118 | Interventions Related to Medication Management | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.119 | Interventions Related to Medication Management, Targeted Medication Review | active | 2024-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.120 | Interventions Related to Medication Management, Discussion | active | 2021-03 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.121 | Reasons for Interventions Related to Medication Management, Cost | active | 2019-06 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.122 | Interventions Related to Education, Immunizations | active | 2017-08 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.123 | Status of Recommendations | active | 2023-12 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.124 | Interventions Related to Medication Management, Provision of Documents | active | 2017-08 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.125 | Status of Compliance Ability | active | 2017-08 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.126 | Status of Interventions | active | 2017-08 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.127 | Status of Disease Control | active | 2017-08 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.128 | Status of Compliance | active | 2017-08 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.129 | Occupations of Providers | active | 2019-06 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.130 | Environments of Care | active | 2017-08 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.131 | Findings Related to Medication Management, Body Mass Index | active | 2017-08 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.132 | Findings Related to Medication Management, Alcohol Use | active | 2019-06 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.133 | Findings Related to Medication Management, Caffeine Use | active | 2019-06 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.134 | Interventions Related to Education, Diet | active | 2024-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.136 | Findings Related to Medication Management, Exercise | active | 2017-08 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.137 | Interventions Related to Education, Behavior | active | 2023-12 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.138 | Findings Related to Medication Management, Diet | active | 2021-03 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.139 | Status of Care Goal | active | 2017-08 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.140 | Findings Related to Medication Management, Illicit Drug Use | active | 2020-09 | us | hl7 | sct |